Newer Insights Into Why the SGLT2s Reduce Heart Failure in Patients With Diabetes

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Newer Insights Into Why the SGLT2s Reduce Heart Failure in Patients With Diabetes

By ASPC 2019 Congress on CVD Prevention FEATURING Robert Chilton

0 views

August 9, 2019

Comments 0

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Ambulatory Blood Pressure Monitoring